Price $293.31 |
Market Cap
234.72B
|
Sector Health Care |
Div. Growth
11.40%
|
|
P/E
42.4
|
P/B
5.86
|
P/S
8.38
|
Dividend %
0.30%
|
|
P/CF
-
|
P/FCF
37.9
|
Op. Cash Flow
8.25M
|
FCF
8.6
|
|
Op. Margin
24.60%
|
Net Margin
20.40%
|
ROE
14.90%
|
ROI
6.60%
|
|
ROA
7.30%
|
EPS Growth
59.30%
|
Current Ratio
1.9
|
Debt/Equity
58.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Genesis Healthcare Inc (GENN) | $0.18 | - | - | 29.3M | Strong Buy |
| Mediwound Ltd (MDWD) | $2.89 | - | - | 67.3M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.66 | - | - | 68.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $64.93 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.21 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
